USANA HEALTH SCIENCES INCUSNA
USANA HEALTH SCIENCES INC Segments Disclosure
SEGMENT INFORMATION
The Company primarily operates as a global nutrition, personal health and wellness company that develops and manufactures high quality, science-based nutritional, and personal care products. As of January 3, 2026, the Company had two reportable segments: Core nutritional and Hiya direct-to-consumer. Management identifies segments based upon the Company's organizational and management reporting structure. The core nutritional segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the core nutritional channel. Hiya is a leading provider of high-quality children’s health and wellness products in the U.S. that are distributed through the direct-to-consumer channel. Additionally, the Company has operating segments that are not material and included as a component of the other category.
The operating segments reflect the Company's primary sales channels and represent the way the chief operating decision maker ("CODM") evaluates the Company's business performance and allocates resources. The CODM is the Company's Chief Executive Officer. The CODM evaluates the performance of each segment based on segment earnings from operations in order to determine how to allocate the Company's resources across its operating segments, including allocating capital and personnel. The CODM does not evaluate operating segments using asset information, accordingly, the Company does not report asset information by segment.
Summarized financial information for the Company’s reportable segments is shown in the following tables, including significant segment expenses that are regularly reviewed by the CODM.
| Year Ended | |||||||||||||||||||||||
| 2025 | |||||||||||||||||||||||
| Core nutritional | Hiya direct-to-consumer | Other | Total | ||||||||||||||||||||
Net Sales (1) | $ | 775,452 | $ | 131,971 | $ | 17,834 | $ | 925,257 | |||||||||||||||
| Less: | |||||||||||||||||||||||
| Cost of sales | 141,847 | 46,384 | 12,621 | 200,852 | |||||||||||||||||||
| Brand Partner incentives | 335,631 | — | 540 | 336,171 | |||||||||||||||||||
Selling, general and administrative (2) | 244,614 | 82,181 | 10,577 | 337,372 | |||||||||||||||||||
| Impairment | 6,390 | — | 577 | 6,967 | |||||||||||||||||||
| Cost realignment | 6,463 | — | — | 6,463 | |||||||||||||||||||
| Segment earnings (loss) from operations | $ | 40,507 | $ | 3,406 | $ | (6,481) | $ | 37,432 | |||||||||||||||
| Reconciliation of segment earnings from operations | |||||||||||||||||||||||
| Interest income | 2,415 | ||||||||||||||||||||||
| Interest expense | (842) | ||||||||||||||||||||||
| Other, net | 2,522 | ||||||||||||||||||||||
| Earnings before income taxes | $ | 41,527 | |||||||||||||||||||||
______________________________
(1)The core nutritional segment excludes $14,091 of intersegment net sales.
(2)Includes amortization of acquired intangible assets of $18,170 and $1,244 for the Hiya segment and the other category, respectively.
| Year Ended | |||||||||||||||||||||||
| 2024 | |||||||||||||||||||||||
| Core nutritional | Hiya direct-to-consumer | Other | Total | ||||||||||||||||||||
Net Sales (1) | $ | 845,789 | $ | 1,970 | $ | 6,744 | $ | 854,503 | |||||||||||||||
| Less: | |||||||||||||||||||||||
| Cost of sales | 157,094 | 598 | 3,520 | 161,212 | |||||||||||||||||||
| Brand Partner incentives | 363,183 | — | 516 | 363,699 | |||||||||||||||||||
Selling, general and administrative (2) | 254,733 | 1,226 | 7,309 | 263,268 | |||||||||||||||||||
| Segment earnings (loss) from operations | $ | 70,779 | $ | 146 | $ | (4,601) | $ | 66,324 | |||||||||||||||
| Reconciliation of segment earnings from operations | |||||||||||||||||||||||
| Interest income | 11,319 | ||||||||||||||||||||||
| Interest expense | (281) | ||||||||||||||||||||||
| Other, net | (1,011) | ||||||||||||||||||||||
| Earnings before income taxes | $ | 76,351 | |||||||||||||||||||||
______________________________
(1)The core nutritional segment excludes $2,087 of intersegment net sales.
(2)Includes amortization of acquired intangible assets of $294 and $1,180 for the Hiya segment and the other category, respectively.
| Year Ended | |||||||||||||||||
| 2023 | |||||||||||||||||
| Core nutritional | Other | Total | |||||||||||||||
Net Sales (1) | $ | 915,212 | $ | 5,798 | $ | 921,010 | |||||||||||
| Less: | |||||||||||||||||
| Cost of sales | 173,432 | 3,261 | 176,693 | ||||||||||||||
| Brand Partner incentives | 393,932 | 325 | 394,257 | ||||||||||||||
Selling, general and administrative (2) | 251,495 | 5,494 | 256,989 | ||||||||||||||
| Segment earnings (loss) from operations | $ | 96,353 | $ | (3,282) | $ | 93,071 | |||||||||||
| Reconciliation of segment earnings from operations | |||||||||||||||||
| Interest income | 9,637 | ||||||||||||||||
| Interest expense | (262) | ||||||||||||||||
| Other, net | 7 | ||||||||||||||||
| Earnings before income taxes | $ | 102,453 | |||||||||||||||
______________________________
(1)The core nutritional segment excludes $1,425 of intersegment net sales.
(2)Includes amortization of acquired intangible assets of $1,180 for the other category.
| Year Ended | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Depreciation and amortization: | |||||||||||||||||
| Core nutritional | $ | 13,492 | $ | 12,851 | $ | 11,855 | |||||||||||
| Hiya direct-to-consumer | 18,230 | 294 | — | ||||||||||||||
| Other | 840 | 1,394 | 847 | ||||||||||||||
| Consolidated Total | $ | 32,562 | $ | 14,539 | $ | 12,702 | |||||||||||
No single Brand Partner or customer accounted for 10% or more of net sales for the periods presented. The table below summarizes the approximate percentage of total product revenue for our core nutritional and Hiya direct-to-consumer segments that has been contributed by the Company’s core nutritional, foods, and personal care and skincare products for the periods indicated.
| Year Ended | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Core nutritional: | |||||||||||||||||
| USANA Nutritionals | 74% | 87% | 87% | ||||||||||||||
USANA Foods (1) | 5% | 6% | 7% | ||||||||||||||
| Personal care and skincare | 5% | 6% | 5% | ||||||||||||||
| Hiya direct-to-consumer: | |||||||||||||||||
| Hiya nutritional supplements | 13% | —% | —% | ||||||||||||||
| Other | 3% | 1% | 1% | ||||||||||||||
______________________________
(1)Includes the Company’s Active Nutrition line
Financial information on net sales and long-lived assets (excluding intangible assets), presented by geographic region is listed below:
| Year Ended | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Net Sales to External Customers | |||||||||||||||||
| Asia Pacific | |||||||||||||||||
| Greater China | $ | 424,541 | $ | 457,976 | $ | 475,099 | |||||||||||
| Southeast Asia Pacific | 131,996 | 146,795 | 163,890 | ||||||||||||||
| North Asia | 70,627 | 78,214 | 101,446 | ||||||||||||||
| Asia Pacific Total | 627,164 | 682,985 | 740,435 | ||||||||||||||
Americas and Europe(1) | 298,093 | 171,518 | 180,575 | ||||||||||||||
| Consolidated Total | $ | 925,257 | $ | 854,503 | $ | 921,010 | |||||||||||
______________________________
(1)Includes results of the Hiya direct-to-consumer segment and the other category.
| January 3, 2026 | December 28, 2024 | ||||||||||
| Long-lived Assets | |||||||||||
| Asia Pacific | |||||||||||
| Greater China | $ | 32,577 | $ | 31,668 | |||||||
| Southeast Asia Pacific | 16,737 | 13,893 | |||||||||
| North Asia | 7,467 | 8,820 | |||||||||
| Asia Pacific Total | 56,781 | 54,381 | |||||||||
Americas and Europe (1) | 80,304 | 83,460 | |||||||||
| Consolidated Total | $ | 137,085 | $ | 137,841 | |||||||
| Total Assets | |||||||||||
| Asia Pacific | |||||||||||
| Greater China | $ | 194,655 | $ | 202,428 | |||||||
| Southeast Asia Pacific | 50,756 | 44,793 | |||||||||
| North Asia | 25,110 | 25,930 | |||||||||
| Asia Pacific Total | 270,521 | 273,151 | |||||||||
Americas and Europe (1) | 472,394 | 475,042 | |||||||||
| Consolidated Total | $ | 742,915 | $ | 748,193 | |||||||
______________________________
(1)Includes balances of the Hiya direct-to-consumer segment and the other category.
The following table provides further information on markets representing ten percent or more of consolidated net sales and long-lived assets (excluding intangible assets), respectively:
| Year Ended | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Net sales: | |||||||||||||||||
| China | $ | 381,816 | $ | 413,471 | $ | 427,265 | |||||||||||
United States (1) | 224,890 | 91,796 | 95,906 | ||||||||||||||
| South Korea | 68,856 | 76,445 | 99,108 | ||||||||||||||
| Long-lived Assets: | |||||||||||||||||
| United States | $ | 77,137 | $ | 81,459 | |||||||||||||
| China | 29,556 | 29,304 | |||||||||||||||
______________________________
(1)Includes results of the Hiya direct-to-consumer segment and the other category.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2026 | Mar 16, 2026 | Showing above |
| 2024 | Mar 12, 2025 | |
| 2023 | Feb 27, 2024 | |
| 2022 | Feb 28, 2023 | |
| 2021 | Mar 2, 2021 | |
| 2019 | Feb 25, 2020 | |
| 2018 | Feb 26, 2019 | |
| 2017 | Feb 28, 2018 | |
| 2016 | Mar 1, 2017 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.